On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections is a paper indexed in ScholarIQ from OpenAlex.
How many citations does On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections have?
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections has 92 citations in the OpenAlex counts ScholarIQ stores.
When was On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections published?
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections has 2019 year in the ScholarIQ index.
What is the open-access status of On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections?
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections has closed oa status in the ScholarIQ index.
What is the DOI of On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections?
The DOI for On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections is on the source record.
What is the PMID of On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections?
The PMID for On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections is on the source record.
What is the OpenAlex record for On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections?
The OpenAlex for On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections is on the source record.